Go to content
UR Home

Entries of Ignatov, Tanja on the publication server

Up a level
Export as
[feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Date | Item type | No Grouping
Jump to: 2021 | 2020 | 2019 | 2018 | 2013
Number of items: 12.

2021

Ignatov, Tanja, Gaßner, Johannes, Bozukova, Mihaela, Ivros, Stylianos, Mészáros, József, Ortmann, Olaf , Eggemann, Holm and Ignatov, Atanas (2021) Contralateral lymph node metastases in patients with vulvar cancer and unilateral sentinel lymph node metastases. Acta Obstetricia et Gynecologica Scandinavica 100, pp. 1520-1525.

2020

Ignatov, Atanas , Papathemelis, Thomas, Ivros, Stylianos, Ignatov, Tanja, Ortmann, Olaf and Eggemann, Holm (2020) Comparison of survival of patients with endometrial cancer undergoing sentinel node biopsy alone or systematic lymphadenectomy. Archives of Gynecology and Obstetrics 302, pp. 995-1000. Fulltext not available.

Schüler-Toprak, Susanne, Skrzypczak, Maciej, Ignatov, Tanja, Ignatov, Atanas, Ortmann, Olaf and Treeck, Oliver (2020) G protein-coupled estrogen receptor 1 (GPER-1) and agonist G-1 inhibit growth of ovarian cancer cells by activation of anti-tumoral transcriptome responses: impact of GPER-1 mRNA on survival. Journal of Cancer Research and Clinical Oncology 146 (12), pp. 3175-3188. Fulltext not available.

Ignatov, Tanja, Treeck, Oliver, Kalinski, Thomas, Ortmann, Olaf and Ignatov, Atanas (2020) GPER-1 expression is associated with a decreased response rate to primary tamoxifen therapy of breast cancer patients. Archives of Gynecology and Obstetrics 301 (2), pp. 565-571. Fulltext not available.

2019

Ignatov, Tanja, Claus, Maria, Nass, Norbert , Haybaeck, Johannes, Seifert, Bernd, Kalinski, Thomas, Ortmann, Olaf and Ignatov, Atanas (2019) G-protein-coupled estrogen receptor GPER-1 expression in hormone receptor-positive breast cancer is associated with poor benefit of tamoxifen. Breast Cancer Research and Treatment 174 (1), pp. 121-127. Fulltext not available.

Ignatov, Tanja, Gorbunow, Franceska, Eggemann, Holm, Ortmann, Olaf and Ignatov, Atanas (2019) Loss of HER2 after HER2-targeted treatment. Breast Cancer Research and Treatment 175 (2), pp. 401-408. Fulltext not available.

Ignatov, Atanas, Lebius, Christin, Ignatov, Tanja, Ivros, Stylianos, Knueppel, Robert, Papathemelis, Thomas, Ortmann, Olaf and Eggemann, Holm (2019) Lymph node micrometastases and outcome of endometrial cancer. Gynecologic Oncology 154 (3), pp. 475-479. Fulltext not available.

2018

Ignatov, Tanja, Eggemann, Holm, Costa, Serban Dan, Ortmann, Olaf and Ignatov, Atanas (2018) Endometrial cancer subtypes are associated with different patterns of recurrence. Journal of Cancer Research and Clinical Oncology 144 (10), pp. 2011-2017. Fulltext not available.

Eggemann, Holm, Ignatov, Tanja, Geyken, Christina Henrike, Seitz, Stephan and Ignatov, Atanas (2018) Management of elderly women with cervical cancer. Journal of Cancer Research and Clinical Oncology 144 (5), pp. 961-967. Fulltext not available.

Ignatov, Tanja, Eggemann, Holm, Burger, Elke, Ortmann, Olaf, Costa, Serban Dan and Ignatov, Atanas (2018) Ovarian metastasis in patients with endometrial cancer: risk factors and impact on survival. Journal of Cancer Research and Clinical Oncology 144 (6), pp. 1103-1107. Fulltext not available.

Hass, Peter , Seinsch, Selvi, Eggemann, Holm, Ignatov, Tanja, Seitz, Stephan and Ignatov, Atanas (2018) Vaginal brachytherapy for endometrial cancer. Journal of Cancer Research and Clinical Oncology 144 (8), pp. 1523-1530. Fulltext not available.

2013

Ignatov, Tanja, Modl, Saskia, Thulig, Maike, Weißenborn, Christine, Treeck, Oliver, Ortmann, Olaf, Zenclussen, Ac, Costa, Serban-Dan, Kalinski, Thomas and Ignatov, Atanas (2013) GPER-1 acts as a tumor suppressor in ovarian cancer. Journal of ovarian research 6 (1), p. 51.

This list was generated on Tue Dec 3 16:36:01 2024 CET.
  1. Homepage UR

University Library

Publication Server

Contact:

Publishing: oa@ur.de
0941 943 -4239 or -69394

Dissertations: dissertationen@ur.de
0941 943 -3904

Research data: datahub@ur.de
0941 943 -5707

Contact persons